Cellular Immunotherapy Team
Research
Research focus of our team is immune cell mediated drug targeting. By combining immune cell based therapeutic strategies with innovative drug delivery concepts we aim at developing novel therapeutic options for the treatment of cancer. Using living immune cells, which have an intrinsic ability of tracing and infiltrating diseased sites, as transport system for anti-cancer drugs ensures that the toxic pharmaceuticals are selectively delivered to the tumor tissue. Moreover, relatively small drug amounts can be administered to bring therapeutically effective doses to the site of action. Thus, strong adverse effects typically caused by systemic chemotherapies are unlikely to occur. (For more detailed information see Annual Report 2010 and Annual Report 2011.)
Team
Team leader |
 |
Dr. Anja Philippi
+49 (0)681 9382 223
+49 (0)681 9382 249
a.philippi@kist-europe.de
|
| Short CV |
| Since 04/2010 | Team leader at KIST Europe, Saarbruecken, Germany |
| 2008 - 2010 | Postdoc in the Medtronics department, KIST Europe, Saarbruecken, Germany |
| 2002 - 2007 | PhD student in the group of Prof. Dr. Herbert Tschochner, Biochemistry Center, University of Heidelberg, Germany and Biochemistry III, University of Regensburg, Germany |
| 1998 - 2001 | Study of Biology (Diplom) at the University of Saarland, Saarbruecken, Germany |
| 1992 - 1998 | Study of Chemistry and Biology (teacher training) at the University of Saarland, Saarbruecken, Germany |
| Publications: Listed on PubMed.gov |
PhD students |
 |
André-René Blaudszun
+49 (0)681 9382 259
+49 (0)681 9382 249
a.blaudszun@kist-europe.de
|
 |
Ruth Eggers
+49 (0)681 9382 225
+49 (0)681 9382 249
r.eggers@kist-europe.de
|
|
 |
Michelle Seif
+49 (0)681 9382 467
+49 (0)681 9382 249
michelle.seif@kist-europe.de
|
|
Technical assistant |
 |
Birgit Wiegand
+49 (0)681 9382 467
+49 (0)681 9382 249
b.wiegand@kist-europe.de
|
Patents & Publications
Patents
- Implantierbarer Mikrozellprozessor zur Krankheitsbehandlung. Registration, April 2009, Germany.
- Cell modification method and cell modification device. Application, February 2009, China, Europe, Korea, USA.
- Zellprozessor zur Krankheitsbehandlung. Registration, February 2008, Germany.
- Cell processor for use in the treatment of diseases. Application, September 2006, USA.
Publications
- Stöhr, T.; Blaudszun, A.-R.; Steinfeld, U.; Wenz, G.: Synthesis of glycosylated peptides by NCA polymerization for recognition of human T-cells. Polym. Chem. 2 (2011) 2239-2248. DOI: 10.1039/C1PY00187F
- Salieb-Beugelaar, G.B.; Simone, G.; Arora, A.; Philippi, A.; Manz, A.: Latest Developments in Microfluidic Cell Biology and Analysis Systems. Anal. Chem. 82 (12) (2010) 4848-4864. DOI: 10.1021/ac1009707
Collaborations
Juniorprof. Dr. Marc Schneider, Pharmaceutical Nanotechnology, University of Saarland, Saarbruecken, Germany
Dr. Frank Breinig, Molecular and Cell Biology, University of Saarland, Saarbruecken, Germany
Positions
Studentinnen und Studenten mit Interesse an einem Fortgeschrittenenpraktikum, einer Bachelor-, Master- oder Diplomarbeit wenden sich bitte an Dr. Anja Philippi (Tel.: 0681-9382-223, E-Mail: a.philippi@kist-europe.de).
Students interested in practical courses, bachelor’s, master’s or diploma work should contact Dr. Anja Philippi (phone: 0681-9382-223, e-mail: a.philippi@kist-europe.de).